Skip to main content
  • Original Article
  • Published:

Potential probiotic properties of lactic acid bacteria isolated from the intestinal mucosa of healthy piglets

Abstract

In the present study, the probiotic properties of 52 lactic acid bacteria strains, isolated from the intestinal mucosa of 60-day-old healthy piglets, were evaluated in vitro in order to acquire probiotics of potential application. Based on acidic and bile salt resistance, 11 lactic acid bacteria strains were selected, among which 1 was identified as Pediococcus acidilactici, 3 as Enterococcus faecium, 3 as Lactobacillus rhamnosus, 2 as Lactobacillus brevis, and 2 as Lactobacillus plantarum by 16S rRNA gene sequencing. All selected strains were further investigated for transit tolerance in simulated upper gastrointestinal tract, for adhesion capacity to swine intestinal epithelial cells J2 (IPEC-J2), for cell surface characteristics including hydrophobicity, co-aggregation and auto-aggregation, and for antimicrobial activities. Moreover, hemolytic, bile salt hydrolase and biogenic amine-producing abilities were investigated for safety assessment. Two E. faecium (WEI-9 and WEI-10) and one L. plantarum (WEI-51) exhibited good simulated upper gastrointestinal tract tolerance, and showed high auto-aggregation and co-aggregation with Escherichia coli 1570. The strains WEI-9 and WEI-10 demonstrated the highest adherence capacity. The 11 selected strains mentioned above exhibited strong antimicrobial activity against E. coli CVCC1570, Staphylococcus aureus CVCC1882 and Salmonella pullorum AS1.1859. None of the 11 selected strains, except WEI-9 and WEI-33, exhibited bile salt hydrolase, hemolytic or biogenic amine-producing abilities. This work showed that the E. faecium WEI-10 and L. plantarum WEI-51were found to have the probiotic properties required for use as potential probiotics in animal feed supplements.

Introduction

Probiotics are defined as “live microorganisms which, when administrated in adequate amounts, confer a health benefit on the host” (FAO/WHO 2002). The gastrointestinal tract is considered the main sources for isolation of novel promising probiotic microorganisms (Ambadoyiannis et al. 2004). The most studied probiotics belongs to Lactobacillus and Bifidobacterium genera, and, among them, Lactobacillus species are commensal and non-pathogenic inhabitants of human and animal intestine, and have been considered as valuable probiotic microorganisms since they contribute to the inhibition to harmful intestinal bacteria (Walter 2008). A potential probiotic strain is expected to have several desirable properties to exert its beneficial effects. It has been reported that the basic criteria for lactic acid bacteria strains to be used as probiotics include the following: (1) they should be generally recognized as safe (GRAS); (2) they should be acid and bile salt resistant and survive in the gastrointestinal tract; (3) they should be able to adhere to the intestinal epithelium of the hosts; (4) they should demonstrate antimicrobial activity against enteric pathogens; and (5) they should be able to keep their viability during processing and storage (Kumar and Kumar 2015).

Therefore, the aims of the present study were to evaluate, in vitro, the functional and safety characteristics, including resistance to acid and bile, tolerance to simulated upper gastrointestinal tract, adhesion capacity to IPEC-J2, hydrophobicity, aggregation and co-aggregation, antimicrobial activity, hemolytic, bile salt hydrolase activity and biogenic amine-producing ability, of potential probiotic lactic acid bacteria, isolated from the intestinal mucosa of 60-day-old healthy piglets.

Materials and methods

Bacterial strains and culture conditions

In our previous work, 52 lactic acid bacteria were isolated from the intestinal mucosa of 60-day-old healthy piglets. The method of isolation was as follows: the gastrointestinal digestive tracts and mucosa collected from healthy weaning piglets (n = 48, approximate 60-day-old, from farms in the northern part of China) were diluted 10-fold in 0.85% (w/v) NaCl and plated on MRS (de Man-Rogosa Sharpe) agar (Hopebiol, China). Incubation was conducted at 37°C for 48 h. Colonies with different morphological features were picked randomly, purified and stored on MRS agar for further testing. When needed, all 52 lactic acid bacteria were cultured in MRS broth (Hopebiol, China), and incubated statically at 37°C for 24–48 h. Indicator strains for antimicrobial assays were Escherichia coli CVCC1570, Staphylococcus aureus CVCC1882 and Salmonella pullorum AS1.1859, respectively, which were purchased from the China Veterinary Culture Collection Center (CVCC, China). These strains are pathogenic bacteria that may cause gastrointestinal disease of swine or poultry. When needed, these three indicator bacteria were grown in LB broth (Hopebiol, China) at 37°C, 200 rpm for 16–18 h. All the isolated lactic acid bacteria and indicator bacteria were cultured in MRS broth or LB broth respectively, and stored by freezing (−80°C) in MRS or LB broth supplemented with 20% (v/v) sterilized glycerol.

Preparation of simulated gastric juice and small intestinal juice

Simulated gastric juice (SGJ) was prepared as described (Fernandez et al. 2003) from NaCl (125 mmol/L), NaHCO3 (45 mmol/L), KCl (7 mmol/L) and pepsin (3 g/L). The salts were purchased from Sinoreagent (China), and pepsin from Sigma-Aldrich (St. Louis, MO). Aliquots of gastric juice were adjusted to pH value 3.0.

Simulated small intestinal juice (SSIJ) was prepared from 0.1% (w/v) pancreatin (Sigma-Aldrich) and 0.3% (w/v) pig bile salt (Aoboxing Bio-Tech, Beijing, China). Aliquots of small intestinal juice were adjusted to pH value 8.0.

Resistance to low pH

Tolerance to low pH was assessed as described by Anandharaj et al. (2015), with minor modifications. Briefly, resistance to low pH of all isolated strains was examined in MRS broth of pH values 1.0, 2.0 or 3.0 adjusted with hydrochloric acid (1 M). Fresh bacterial cultures from MRS agar slants were inoculated into MRS broth and incubated at 37°C for 14 h. The bacterial cultures were then inoculated into MRS broth of pH values 1.0, 2.0 or 3.0, respectively, at an inoculum size of 1% (v/v), and incubated at 37°C for 11 h. Conventional nonacidified MRS (pH 6.2) was used as a control. Enumeration of the viable cell counts was achieved by surface plating on MRS agar followed by incubation at 37°C for 48 h. The survival rate was calculated as log 10 values of colony-forming units per milliliter (CFU/mL). The experiments were performed in triplicate and mean values were calculated.

Survival rate was calculated as:

$$ \%\ \mathrm{Resistance}=\left(\raisebox{1ex}{$\mathrm{Viable}\ \mathrm{cell}\ counts\ in\ MRS\ broth\ at\ \mathrm{pH}\ 1.0,\ 2.0,\ 3.0$}\!\left/ \!\raisebox{-1ex}{$\mathrm{Viable}\ \mathrm{cell}\ counts\ in\ MRS\ broth\ at\ \mathrm{pH}\ 6.2$}\right.\right)\times 100\kern1em (1) $$
(1)

Resistance to bile salts

The resistance to bile salts of all strains was assayed following the method of Anandharaj and Sivasankari (2014), with minor modifications. Briefly, tolerance of selected lactic acid bacteria strains to various bile salt concentrations was determined using MRS broth containing bile salts at different concentration (0.1%, 0.3%, 0.5%, w/v). Fresh bacterial cultures from MRS agar slants were inoculated into MRS broth, and incubated at 37°C for 14 h. Bacterial cultures were then inoculated into MRS broth with pig bile salt concentrations of 0.1%, 0.3% or 0.5%, respectively, at an inoculum size of 1% (v/v), and incubated at 37°C for 9 h. MRS broth without bile salts was used as control. Enumeration of the viable cell counts was achieved by surface plating on MRS agar followed by incubation at 37°C for 48 h. The survival rate was calculated as log 10 values of CFU/mL. The experiments were performed in triplicate and mean values were calculated.

Survival rate was calculated as:

$$ \%\ \mathrm{Resistance}=\left(\raisebox{1ex}{$\mathrm{Viable}\ \mathrm{cell}\ counts\ in\ MRS\ broth\ with\ bile\ salts$}\!\left/ \!\raisebox{-1ex}{$\mathrm{Viable}\ \mathrm{cell}\ counts\ in\ MRS\ broth\ with out\ bile\ salts$}\right.\right)\times 100 $$
(2)

Molecular identification of lactic acid bacteria

On the basis of the resistance to low pH and bile salts characteristics of the 52 lactic acid bacteria described above, 11 strains demonstrating good resistance to low pH and bile salts were subjected to genetic identification using 16S rRNA gene sequencing. Briefly, genomic DNA was extracted by UniversalGen DNA Kit (TianGEN, China). PCR amplification of the 16S rRNA gene was performed using the universal prokaryotic primers SD-Bact-0008-a-S-20 (27 F; 5′AGAGTTTGATCCTGGCTCAG 3′) and SD-Bact-1492-a-A-19 (1492R; 5′ TACCTTGTTACGACTT 3′). The polymerase chain reaction (PCR) reaction mix consisted of 1.0 μL template, 2.5 μL 10-fold diluted Taq DNA Polymerase Buffer (containing Mg2+), 1 μL deoxynucleoside triphosphate (dNTP, 2.5 mmol/L, TaKaRa), 0.5 μL of each primer (10 μmol/L), 0.125 μL Taq DNA polymerase (5 U/μL, TaKaRa) and 25 μL DNase-RNase-free water (ComWin Biotech, China). Each PCR cycling profile consisted of an initial denaturation step (5 min at 95°C), followed by amplification for 30 cycles as follows: denaturation for 1 min at 95°C, annealing for 1 min at 55°C, an extension for 1.5 min at 72°C. PCR was completed with an elongation phase (10 min at 72°C). The amplified PCR products were purified using the QIAquick PCR kit and amplicons were sequenced (forward and reverse sequence) by SinoGenoMax, Beijing, China. The sequence was compared with the nucleotide database of the NCBI GenBank using the BLAST program. A similarity of >99% to the 16S rRNA gene sequence of the known lactic acid bacteria recorded in the database was used as a criterion for the identification.

Resistance to simulated gastric juice

Resistance to simulated gastric juice was determined according to Tulini et al. (2013), with slight modifications. Fresh bacterial cultures from MRS agar slants were inoculated into MRS broth and were incubated at 37°C for 14 h. Fresh cultures were harvested by centrifugation at 7000 g for 10 min and re-suspended in 0.85% (w/v) sterile saline solution. Dilutions were made to achieve a final cell density of 109 CFU/mL. Thereafter, 0.5 mL each cell suspension and 4.5 mL simulated gastric juice were mixed by vortexing for 10 s and incubated at 37°C for 3 h. The cell suspensions at 0 h were used as a control. To determine viable cell counts, serial dilutions were placed on MRS agar and incubated at 37°C for 48 h before enumeration of CFUs. The survival rate was calculated as log 10 values of CFU/mL. The experiments were performed in triplicate and mean values were calculated.

Survival rate was calculated as:

$$ \%\ \mathrm{Resistance}=\left(\raisebox{1ex}{$\mathrm{Viable}\ \mathrm{cell}\ counts\ in\ simulated\ gastric\ juice\ at\ 3\ h$}\!\left/ \!\raisebox{-1ex}{$\mathrm{Viable}\ \mathrm{cell}\ counts\ at\ 0\ h$}\right.\right)\times 100 $$
(3)

Resistance to simulated gastrointestinal tract

The resistance to simulated gastrointestinal tract conditions was examined according to the protocol of Fernandez et al. (2003), with slight modifications. Fresh bacterial cultures from the MRS agar slants were inoculated into MRS broth and were incubated at 37°C for 14 h. Fresh cultures were harvested by centrifugation at 7000 g for 10 min and re-suspended in 0.85% (w/v) sterile saline solution. Dilutions were made to achieve a final cell density of 109 CFU/mL. Thereafter, 0.5 mL each cell suspension and 4.5 mL simulated gastric juice were mixed by vortexing for 10 s and incubated at 37°C for 3 h. Cell suspensions (0.5 mL) treated by simulated gastric juice were taken and mixed with 4.5 mL simulated small intestinal juice. The mixture was again vortexed for 10 s and incubated at 37°C for 6 h. To determine viable cell counts, serial dilutions were placed on MRS agar and incubated at 37°C for 48 h before enumeration of CFUs. The survival rate was calculated as log 10 values of CFU/mL. The experiments were performed in triplicate and mean values were calculated.

Survival rate was calculated as:

$$ \%\ \mathrm{Resistance}=\left(\raisebox{1ex}{$\mathrm{Viable}\ \mathrm{cell}\ counts\ in\ simulated\ small\ in testinal\ juice\ at\ 6\ h$}\!\left/ \!\raisebox{-1ex}{$\mathrm{Viable}\ \mathrm{cell}\ counts\ at\ 0\ h$}\right.\right)\times 100 $$
(4)

Adhesion capacity to IPEC-J2

The adhesion capacity to IPEC-J2 of all 11 selected strains was examined as described by Sarem et al. (1996) and Crociani et al. (1995) after slight modification as follows. The IPEC-J2 was donated by Beijing University of Agriculture. The cells were cultured in Dulbecco’s modified Eagle’s minimal essential medium (DMEM; HyClone Laboratories Inc., Logan, UT) supplemented with 10% (v/v) fetal calf serum (Gibco), 100 U/mL penicillin and 100 mg/mL streptomycin at 37°C and 5% CO2. For the adhesion assay, cell monolayers were detached from culture dishes by trypsin treatment and then transferred to 6-well cell culture plates. Cells were seeded at a cell density of 2 × 105 – 4 × 105 cells per well, and grown to confluence. The cell culture medium was changed every day and replaced with fresh supplemented DMEM without antibiotics at least 1 h before the adhesion assay.

Fresh bacterial cultures from MRS agar slants were inoculated into MRS broth and then incubated at 37°C for 14 h. Cell cultures were harvested by centrifugation, washed twice with PBS buffer (pH 7.4), suspended in supplemented DMEM media without antibiotics, and viable cell counts at a concentration of approximate 108 CFU/mL were then determined. The adhesion of bacterial strains to IPEC-J2 cell was investigated by adding 1 mL bacterial suspension to wells containing IPEC-J2 monolayer. After incubation at 37°C for 2 h, the IPEC-J2 cell cultures were washed three times with PBS, and then treated with 1 mL 0.1% Triton X-100 for 10 min to lyse the IPEC-J2 cells and release the adhered bacteria. The adhesion ratio was calculated by counting on MRS agar plates. Each adhesion assay was carried out in triplicate. The adhesion ratio (%) was calculated using the formula:

$$ \%\ \mathrm{Adhesion}\ \mathrm{ratio}=\left(\mathrm{Viable}\ \mathrm{cell}\ counts\ \mathrm{of}\ \mathrm{adhered}\ \mathrm{bacteria}\ /\mathrm{Viable}\ \mathrm{cell}\ counts\ \mathrm{of}\ \mathrm{suspension}\ \mathrm{before}\ \mathrm{adhesion}\ \mathrm{assay}\right)\times 100 $$
(5)

Hydrophobicity assay

The surface hydrophobicity (H%) of the 11 selected strains was performed as described by Solieri et al. (2014) after slight modification as follows. Fresh bacterial cultures from MRS agar slants were inoculated into MRS broth and then incubated at 37°C for 14 h. Cell cultures were harvested by centrifugation, washed twice with PBS solution (pH 7.4), suspended in PBS buffer and adjusted to around 0.5 (A 0) with an approximate concentration of 107 CFU/mL by measuring the absorbance at 540 nm as preparation. About 3 mL bacterial suspension and 1 mL toluene were mixed by vortexing for 30 s, and incubated at 37°C for 10 min for temperature equilibration. The mixture was again vortexed briefly and incubated at 37°C for 1 h for phase separation. The aqueous phase was gently taken out for measuring absorbance at 540 nm. The surface hydrophobicity (H%) was calculated using the formula:

$$ \mathrm{H}\%=\left[\left({A}_0-{A}_t\right)/{A}_0\right]\times 100 $$
(6)

where, A t and A 0 represented the absorbance of the aqueous phase after mixing and the absorbance of original suspension, respectively.

Auto-aggregation and co-aggregation assay

The auto-aggregation assay was performed according to Solieri et al. (2014) with slight modification as follows. Fresh bacterial cultures from MRS agar slants were inoculated into MRS broth and then incubated at 37°C for 14 h. Cell cultures were harvested by centrifugation, washed twice with PBS solution (pH 7.4), suspended in PBS buffer and adjusted to around 0.5 (A 0) with an approximate concentration of 107 CFU/mL by measuring the absorbance at 540 nm as preparation. Cell suspension (4 mL) in PBS buffer was vortexed for 10 s and incubated at room temperature for 5 h. Thereafter, the upper suspension was taken to measure the absorbance at 540 nm. Auto-aggregation (Auto-A%) was expressed as the percentage decrease in absorbance after 5 h relative to that of original suspension as follows:

$$ \mathrm{Auto}-\mathrm{A}\%=\left[\left({A}_0-{A}_t\right)/{A}_0\right]\times 100 $$
(7)

where A t and A 0 represent the absorbance of at time 5 h and 0 h, respectively.

Co-aggregation ability (Co-A%) was assayed as reported by Solieri et al. (2014). The pathogen strain used was E. coli CVCC1570. The cells suspensions were prepared as above. Equal volumes (2 mL) of suspensions of tested strain and pathogenic strain were mixed together in pairs and vortexed for 10 s. Cell suspensions of each single strain were used as controls. After 5 h at room temperature, absorbance of tested (A x) strains, pathogenic (A y) strains and the mixture [A (x+y)] were measured at 540 nm. Co-aggregation percentage was calculated using the equation:

$$ \mathrm{C}\mathrm{o}-\mathrm{A}\%=\left[1-\frac{A_{\left( x+ y\right)}}{\left({A}_x+{A}_y\right)/2}\right]\times 100 $$
(8)

where x and y represented each of the two strains and (x + y) represented the mixture, respectively.

Antimicrobial activity

Antagonism towards various bacterial pathogens was evaluated according to Wu et al. (2014) with slight modification as follows. The tested strain was grown on MRS agar at 37°C for 48 h. Agar containing cultures were then punched using 8 mm hole puncher and spotted onto the surface of LB agar (Hopebiol, China) previously inoculated with 100 μL an overnight culture of E. coli CVCC1570 (about 108 CFU/mL). Clear zones were measured after overnight incubation at 37°C for 48 h. The 11 strains were further evaluated for their inhibitory activity against the other indicator bacteria, which were Staphylococcus aureus CVCC1882 and Salmonella pullorum AS1.1859, by the same method. Each strain was tested in triplicate.

Safety characteristics

Antibiotic resistance

The following six antimicrobial agents (Solarbio, China) recommended by the European Food Safety Authority (EFSA 2012a) were used: ampicillin and vancomycin as inhibitors of cell wall synthesis; kanamycin, chloramphenicol, tetracycline and streptomycin as inhibitors of protein synthesis. All antibiotic powders were dissolved in appropriate diluents (CLSI 2012) and filter-sterilized prior to addition to MRS medium. Serial dilutions of antibiotics, ranging from 0.25 μg/mL to 256 μg/mL, were prepared, and vancomycin concentrations of 514 μg/mL and 1028 μg/mL were also tested. MRS broth containing antibiotics at different concentrations was used to prepared each well of a micro-well plate. The methods used were according to CLSI document M100-S22 (CLSI 2012). The inoculum was adjusted to a turbidity equivalent of 0.5 McFarland standard (ca. 105 CFU/mL) and was derived from a broth culture that was incubated at 37°C for 18 h. Fresh culture (1 mL) was used to inoculate each well, and incubated at 37°C. Minimal inhibitory concentration (MIC) was determined on MRS broth, since it supported the best growth of all bacteria used in this study. The MIC was defined as the lowest concentration of antibiotic giving a complete inhibition of visible growth in comparison to an antibiotic-free control well. At the same time, the optical density (OD) of cell cultures was evaluated using Microplate Manager Software (Version SkanIt RE for MSS 2.4.2, Thermo) at 600 nm; OD ≤ 0.020 was considered an indicator of transparency.

Evaluation of virulence factors of E. faecium

Strains identified as E. faecium and with a MIC value for ampicillin ≤2 mg/L, should be tested for the genetic elements IS 16, hyl EFM and esp, which are virulence factors and markers that are now considered the most relevant for the assessment of safety (EFSA 2012b). DNA was extracted from bacterial cultures as described previously. The primer sequences are listed in Table 1. The PCR mixture consisted of 1.0 μL template, 2.5 μL diluted 10-fold Taq DNA Polymerase Buffer (containing Mg2+, TaKaRa), 1 μL deoxynucleoside triphosphate (dNTP, 2.5 mmol/L, TaKaRa), 0.5 μL of each primer (10 μmol/L), 0.125 μL Taq DNA polymerase (5 U/μL, TaKaRa) and 25 μL DNase-RNase-free water (ComWin Biotech, Beijing, China). Each PCR cycling profile consisted of an initial denaturation step (5 min at 95°C), followed by amplification for 35 cycles as follows: denaturation for 1 min at 95°C, annealing for 1 min at 52°C, an extension for 42 s at 72°C. PCR was completed with an elongation phase (10 min at 72°C). PCR samples were analyzed using 0.8% (w/v) agarose gels (Biowest, Barcelona, Spain) in 1 × TBE buffer at 130 V for 50 min ,then visualized with ethidium bromide staining using GelDoc2000 (Bio-Rad, Schiltigheim, France). Banding patterns were analyzed using Quantity One Software (Bio-Rad).

Table 1 Primers used for the PCR-based detection of genes responsible for Enterococcus faecium virulence

Hemolytic activity

The methods used were according to Lee et al. (2011), with slight modification as follows. Fresh bacterial cultures were streaked in triplicate on a fresh blood agar plate, containing 5% (w/v) sheep blood, and incubated for 48 h at 37°C. Blood agar plates were examined for signs of β-hemolysis (clear zones around colony), α- hemolysis (green-hued zones around colony) and γ- hemolysis (no zones around colony).

Bile salts hydrolysis

The bile salts hydrolysis was assayed as reported by Argyri et al. (2013). Fresh bacterial cultures were streaked on MRS agar containing 0.5% (w/v) taurodeoxycholic acid in triplicate. The hydrolysis effect was indicated by taurodeoxycholic acid precipitated zones in the agar medium below and around a colony, after incubating at 37°C for 48 h.

Biogenic amine-producing ability

The production of biogenic amines (tyramine, histamine and putrescine) was assessed using decarboxylase medium (tryptone, 5 g/L; yeast extract, 5 g/L; beef extract, 5 g/L; sodium chloride, 2.5 g/L; glucose, 0.5 g/L; Tween-80, 1 g/L;MnSO4 · H2O, 0.5 g/L; MgSO 7H2O, 0.2 g/L; FeSO4 · 7H2O, 0.04 g/L; thiamine, 0.01 g/L; K2HPO 3H2O, 2 g/L; CaCO3, 0.1 g/L; bromcresol purple, 0.06 g/L; pyridoxal-5-phosphate, 0.05 g/L, pH 5.3–5.5) as described by Bover-Cid and Holzapfel (1999). Firstly, fresh bacterial cultures from MRS agar slants were inoculated into MRS broth, incubated at 37°C for 14 h, and then subcultured twice. Thereafter, the cultures were inoculated into MRS broth containing 1% amino acid precursor (tyrosine, histidine and ornithine, respectively, purchased from Sigma, St. Louis, MO) at an inoculum size of 1% (v/v) and incubated at 37°C for 14 h, and then subcultured five times. Finally, the activated cultures were then used to inoculate to decarboxylation liquid medium at an inoculum size of 1% (v/v), and incubated at 37°C for 4 h, and the color change of the medium was then observed, using MRS broth as a control. Compared to blank MRS broth, medium exhibiting both yellow color and turbidity indicated that the strain was negative for biogenic amine-producing ability, while red or purple medium indicated that the strain was positive for biogenic amine-producing ability.

Multiplex PCR was used to detect genes responsible for biogenic amines production, as follows: DNA was extracted from bacterial cultures as described above. The method described by Coton et al. (2010) was used for simultaneous detection of four biogenic amines genes: histamine (histidine decarboxylase, hdc), tyramine (tyrosine decarboxylase, tyrdc) and putrescine (via either ornithine decarboxylase, odc, or agmatine deiminase, agdi) as well as a PCR internal control corresponding to the 16S rRNA coding gene.

Statistical analysis

Results were calculated with mean values, and standard deviations (mean ± SD) were determined from triplicate trials. Statistical significance of the results was evaluated by one-way ANOVA (analysis of variance) and the least significant different (LSD) mean comparison test (P < 0.05) using SPSS 17.0 software.

Results and discussion

The intestinal mucosa, the contents and the feces of livestock represent an alternative and readily source of lactic acid bacteria with promising functional properties. It can also be argued that a probiotic strain will function better in an environment similar to that for which it was originally isolated (Saarela et al. 2000). Strompfova and Laukova (2009) revealed 55 potential functional features of isolates from rectal swab samples and feces collected from 40 heads of healthy suckling and weaning piglets. Macias-Rodriguez et al. (2008) isolated 164 lactobacilli from the feces and the associated mucus from the small intestine and cecum of newborn piglets. In the present study, 52 lactic acid bacteria isolated from the intestinal mucosa of 60-day-old healthy piglets were screened for potential probiotic use. Thus, from security considerations, the source of the selected lactobacilli is safe.

It is noteworthy that evaluation of the functional and safety properties of strains in vitro, which including transit tolerance in simulated upper gastrointestinal tract, adhesion capacity, cell surface characteristics, antimicrobial activities, hemolytic, bile salt hydrolase activities, biogenic amine-producing ability, and so on, is considered important for selection of novel probiotic candidates (Fang et al. 2015; Manhar et al. 2016; Tulumoglu et al. 2013).

Resistance to low pH

The 52 lactic acid bacteria isolated here from the intestinal mucosa of 60-day-old healthy piglets were screened for low pH resistance characteristics. The results are reported in Table 2. Among the tested 52 strains, 8 could not survive at pH 1.0 conditions, among which strains WEI-4, WEI-7, WEI-19, WEI-20 and WEI-23 were the most acid-sensitive strains, with the lowest survival rates of 47.79%, 51.28%, 49.34%, 45.04% and 52.97%, respectively, at pH 3.0. Compared to all other strains, WEI-2, WEI-9, WEI-10, WEI-17, WEI-22, WEI-30, WEI-33, WEI-38, WEI-41, WEI-48 and WEI-51 demonstrated better resistance to pH 3.0, with survival rates of 86.63%, 92.61%, 94.92%, 89.49%, 91.94%, 87.29%, 90.69%, 87.10%, 91.05%, 90.75% and 87.23%, respectively.

Table 2 Effect of pH on the viability of tested lactic acid bacteria incubated at various pH ranges (1, 2, 3 and 6.2), expressed as log CFU/mL and survival rate

Potential probiotic strains must tolerate acidic environments and bile secretions in order to successfully pass through the stomach and small intestine. The pH of the gastric juice is around 2.0–3.0, which causes most ingested microorganisms to die (Singh et al. 2012). In this study, when confronted with various pH conditions, most of the strains, except for WEI-2, WEI-9, WEI-10, WEI-17, WEI-22, WEI-30, WEI-33, WEI-38, WEI-41, WEI-48 and WEI-51, showed a decreased survival rate after exposure to pH 3.0 for 11.5 h. Our results are in agreement with those obtained from previous studies, where lactobacilli of animal, human, or fermented food origin, were able to retain their viability when exposed to pH ranged from 1.0 to 3.0 (Tulumoglu et al. 2013; Anandharaj and Sivasankari 2014).

Resistance to bile salts

The 52 strains were further tested for their tolerance to various bile salt concentrations. Table 3 shows viable cell counts (log CFU/mL) and survival percentages of probiotic strains in MRS broth supplemented with 0.1%, 0.3% and 0.5% bile salts. We found that resistance to bile salts varied significantly among the probiotic strains. Among all strains tested, WEI-2 (85.32%), WEI-9 (86.76%), WEI-10 (88.09%), WEI-17 (82.50%), WEI-22 (85.57%), WEI-30(84.34%), WEI-33 (80.98%), WEI-38 (81.26%), WEI-41 (84.14%), WEI-48 (83.59%) and WEI-51 (85.36%) demonstrated higher resistance to 0.3% bile salts after 9 h, but their survival rate decreased dramatically to between 40.29 and 45.42% when exposed to 0.5% bile salts. WEI-3, WEI-25, WEI-32, WEI-34 and WEI-44 were most sensitive to 0.3% bile salts and almost lost their viability in 0.5% bile salts after 9 h. WEI-2, WEI-9, WEI-10, WEI-17, WEI-22, WEI-30, WEI-33, WEI-38, WEI-41, WEI-48 and WEI-51 exhibited greater resistance to bile salts and also survived well under low pH conditions.

Table 3 Effect of bile salt concentration (0.1%, 0.3% and 0.5%) on the viability of tested lactic acid bacteria, values expressed as log CFU/mL and survival rate

Bile tolerance of probiotics has been revealed to be dependent on bile type and on the strain (Liong and Shah 2005); the mean bile concentration is believed to be 0.3% (w/v) (Prasad et al. 1998). In present study, most of the selected strains were found to be resistance to 0.1% (w/v) bile salts, while the viable counts of bacteria reduced with increased concentrations of bile salts. These 11 strains also survived well under low pH conditions, thus we selected these 11 strains to further probiotic evaluation assay, to acquire the most potential probiotics. Many previous studies also reported that a lot of lactobacilli were resistance to 0.3–0.5% bile salts and confirmed that the resistance to low pH and bile salts is a strain-specific trait (Messaoudi et al. 2012; Toscano et al. 2015; Shobharani and Halami 2016), which is in accordance to our study.

Molecular identification of lactic acid bacteria

The 11 strains, all isolated from the intestinal mucosa of 60-day-old healthy piglets, were selected on the basis of the properties described above, and were identified through 16S rRNA gene sequencing. Results demonstrated that the strain WEI-2 (GenBank accession number: KY041755) belonged to Pediococcus acidilactici species, the strains WEI-9 (GenBank accession number: KY041756), WEI-10 (GenBank accession number: KY041757) and WEI-48 (GenBank accession number: KY041764) belonged to E. faecium species, the strains WEI-17 (GenBank accession number: KY041758), WEI-30 (GenBank accession number: KY041760) and WEI-41 (GenBank accession number: KY041763) belonged to Lactobacillus rhamnosus species, the strains WEI-22 (GenBank accession number: KY041759) and WEI-38 (GenBank accession number: KY041762) belonged to Lactobacillus brevis species, while the strains WEI-33 (GenBank accession number: KY041761) and WEI-51 (GenBank accession number: KY041765) belonged to Lactobacillus plantarum.

Resistance to simulated gastric juice

The same 11 lactic acid bacteria, which exhibited the highest acid and bile resistance, were selected for in vitro resistance to simulated gastric juice (Table 4). The strains WEI-9 and WEI-10 showed the highest resistance to simulated gastric juice, with survival rates above 97%. Followed by WEI-9 and WEI-10, WEI-51 also demonstrated high tolerance to simulated gastric juice after 3 h, and the survival rate reached >90%. Simulated small intestinal juice resistance varied significantly among the strains, among which the viability of the strains WEI-9, WEI-10, WEI-48 and WEI-51 was not affected by exposure to small intestinal juice. A good survival rate was found for WEI-9, WEI-10 and WEI-51 strains.

Table 4 Transit tolerance in simulated upper gastrointestinal tract expressed as viable of lactic acid bacteria. Results are expressed as mean ± SD; n = 3

Results of the tolerance to the simulated upper gastrointestinal tract of the 11 selected strains demonstrate that the low value of pH in the gastric compartment has more influence on strain survival than the presence of bile and pancreatic juice. These results are in agreement with previous studies (Solieri et al. 2014; Pitino et al. 2010). Strains WEI-9, WEI-10, WEI-33, WEI-48 and WEI-51 exhibited high in vitro tolerance to simulated gastric juice and small intestinal juice, among which WEI-9, WEI-10 and WEI-33 belong to E. faecium, and WEI-48 and WEI-51 belong to L. plantarum. Meanwhile, E. faecium WEI-9, WEI-10 and WEI-33 showed higher tolerance to simulated gastric juice and small intestinal juice than L. plantarum WEI-48 and WEI-51, which indicated that E. faecium exhibited higher resistance to simulated gastric juice and small intestinal juice.

Adhesion capacity to IPEC-J2 cells and cell surface characteristics

In the present study, the adhesion to IPEC-J2 cells was determined for 11 tested lactic acid bacteria, and the results are illustrated in Fig. 1. Adhesion capacity to IPEC-J2 cells varied significantly among the 11 lactic acid bacteria, of which the adhesion ratio was from 40% to 95%. The highest adherence capacity (more than 90%) was demonstrated from strains WEI-9 and WEI-10, and had significant difference (P < 0.05) compared to that of other strains.

Fig. 1
figure 1

Adhesion ability to the IPEC-J2 of the selected lactic acid bacteria. Adhesion capacity was calculated as the percentage of adhered lactic acid bacteria in relation to the total number of strains added. Error bars Standard deviation from three replications. Values within each column that do not sharing a common letter are significantly different (P < 0.05) according to the least significant different (LSD) mean comparison test

The 11 lactic acid bacteria were further evaluated for cell surface hydrophobicity associated to adhesion capacity, and the results are shown in Fig. 2. The cell hydrophobicity of the 11 selected strains ranged from 8% to 92%. Two strains (WEI-9 and WEI-10) exhibited good hydrophobic cell surface, with a percentage higher than 85%, and had significant difference (P < 0.05) compared to other strains.

Fig. 2
figure 2

Hydrophobicity, auto-aggregation and co-aggregation with Escherichia coli CVCC1570 of lactic acid bacteria. Error bars Standard deviation from three replications. Values within each column that do not sharing a common letter are significantly different (P < 0.05) according to the LSD mean comparison test

Results of the co-aggregation ability tests of the 11 selected strains with the pathogen E. coli CVCC1570 are illustrated in Fig. 2. The highest co-aggregation percentages (above 60%) were displayed by the strain WEI-9 and WEI-10, which exhibits significant difference (P < 0.05) compared to other strains.

In this study, the calculated value of auto-aggregation revealed a variable distribution, with percentage ranging from 5% to 70% (Fig. 2). Among the selected strains, WEI-9 and WEI-10 showed the highest auto-aggregation percentages, reaching >55% and with significant difference (P < 0.05) compared to other strains. From the results, we observed that WEI-9 and WEI-10 had better cell surface hydrophobicity, co-aggregation and auto-aggregation capacity compared to other strains.

The ability of the strains to adhere to the mucosal surface is another common criterion for probiotic strain selection, since it is related directly to their colonization and persistence in the gastrointestinal tract (Zuo et al. 2016). Our results for bacterial adherence capacity to IPEC-J2 cells revealed adhesion ability of the 11 selected strains, confirming that this property for lactic acid bacteria is strain dependent (Laparra and Sanz 2009). It is interesting to note that the adhesion ability of lactobacilli has been correlated to cell hydrophobicity, which represents a benefit for bacterial maintenance in the gastrointestinal tract (Kos et al. 2003). Many studies have confirmed that auto-aggregation is an important property of probiotic strains for prevention of pathogens. Probiotic strains with epithelial adherence and co-aggregation properties form a barrier that inhibits colonization of intestinal pathogens (Anandharaj et al. 2015). This work revealed that strains with high adhesion capacity and hydrophobicity, such as WEI-9, WEI-10 and WEI-51, showed high auto-aggregation and co-aggregation abilities, which is in accordance with previous data (Saarela et al. 2000; Pithva et al. 2014). Nevertheless, conflicting evidence, including that adhesive and aggregative properties as well as hydrophobic characteristics are strain dependent, has been reported previously (Solieri et al. 2014).

Antimicrobial activity

The inhibitory abilities of the lactic acid bacteria against E. coli CVCC1570, Staphylococcus aureus CVCC1882 and Salmonella pullorum AS1.1859, considered in the present study, were shown in Table 5. In particular, all strains indicated forceful antimicrobial activity against E. coli CVCC1570 (with inhibition zone higher than 8.0 mm in diameter) and variable activity versus S. aureus CVCC1882 and S. pullorum AS1.1859 strains (Table 5). All strains inhibited not only the growth of Gram-positive bacteria like S. aureus, but also the growth of Gram-negative bacteria like E. coli and S. pullorum, whereas there was no correlation between the capacity to inhibit Gram-positive indicator strains and the capacity to inhibit Gram-negative indicator strains.

Table 5 Antimicrobial activity of lactic acid bacteria against common pathogens, hemolytic activity, bile salt hydrolase (BSH) activity and biogenic amine-producing (BAP) ability of the strains

The ability to produce antimicrobial compounds may be one of the key characteristics for competitive exclusion of pathogen survival in the intestine and expression of a probiotic effect for the host (Collado et al. 2005). All 11 selected strains tested showed forceful activity against E. coli, in agreement with previous work (Tulumoglu et al. 2013; Strompfova and Laukova 2014). However, as previously reported (Pithva et al. 2014), our results also confirmed the strain-specific nature of the antimicrobial activity, in particular against S. aureus CVCC1882 and S. pullorum AS1.1859 strains.

Antibiotic resistance

One of the required properties for probiotic strains is their safety for host consumption without harboring acquired and transferable antibiotic resistance. Table 6 shows the MIC values of 11 selected strains to antibiotics. Strains were considered resistance when they showed MIC values higher than the MIC breakpoints established by the European Food Safety Authority (EFSA 2012a). None of the strains exhibited resistance to ampicillin, streptomycin, or chloramphenicol. On the contrary, all tested strains except WEI-9, WEI-10 and WEI-33, were resistant to vancomycin (without a specific breakpoint from EFSA), which is not transferable to the other species because it is chromosomally encoded (Morrow et al. 2012). The resistance to vancomycin has been attributed to the presence of d-Ala-d-lactate in their peptidoglycan instead of the normal d-Ala-d-Ala, which is the target of the antibiotic (Monteagudo-Mera et al. 2011). Most of the strains revealed sensitivity to tetracycline, confirming the generally lower resistance of the lactobacilli species towards tetracycline (Maragkoudakis et al. 2006). Regarding the antibiotic kanamycin, four strains were resistant to kanamycin. Resistance to kanamycin has already been reported in several Lactobacillus species, and it could be attributable to the absence of cytochrome-mediated electro transport, which mediates drug uptake, and to membrane impermeability (Elkins and Mullis 2004). The low resistance to vancomycin and kanamycin does not represent a safety concern, since the strains exhibited high susceptibility to clinically relevant antibiotics, so could be totally free of transferable antibiotic resistance genes.

Table 6 Minimal inhibitory concentrations (MIC) (in μg/mL) of strains to antibiotics. A Ampicillin, V vancomycin, S streptomycin, K kanamycin, T tetracycline, C chloramphenicol, R resistant

Evaluation of virulence factors of E. faecium

It is now recognized that E. faecium consists of two distinct subpopulations, or clades. One subpopulation [termed community-associated clade B by Palmer et al. (2012) based on whole genome phylogeny] consists predominantly of isolates from the feces of healthy individuals, and is characterized by susceptibility to ampicillin. The other subpopulation (hospital-associated clade A) contains most of the ampicillin-resistant isolates. Comparative genomic hybridization and genome sequencing have revealed the presence of several genes that are enriched in clinical E. faecium isolates. One of the genes that is most clearly over-represented in clinical isolates is the insertion sequence IS16 [hospital associated strain marker, Werner et al. (2011)], which presumably confers a level of genomic flexibility to its host, thereby facilitating the subsequent acquisition of additional elements involved in virulence or antibiotic resistance. Other factors potentially associated with E. faecium virulence have also been identified but, among them, ESP [pathogenicity island (PAI) marker, Top et al. 2011; Rice et al. 2003], and the hyl-like (Freitas et al. 2010) gene are now considered the most relevant for assessment of safety (EFSA 2012b). The purpose of this assessment was to exclude E. faecium strains belonging to the hospital-associated clade from use in animal nutrition because of the hazard they present to a vulnerable subpopulation of consumers. PCR-based detection of genes responsible for antibiotic resistance and virulence was applied to strains belonging to E. faecium (WEI-9, WEI-10 and WEI-33). None of the three genetic elements were detected in WEI-9, WEI-10 and WEI-33 (data not shown), indicating that these three E. faecium strains belonged to the community-associated clade (B), and can be considered safe.

Hemolytic, bile salts hydrolysis and biogenic amine-producing abilities

Table 5 shows the hemolytic activity, bile salts hydrolysis (BSH) and biogenic amine-producing (BAP) ability of the 11 selected strains. None of the strains examined exhibited β-hemolytic activity when grown in fresh blood agar plates; only the strains WEI-33 exhibited α-hemolysis. The absence of hemolytic activity is considered as a safety prerequisite for selection of a probiotic strain (FAO/WHO 2002). None of the strains, excepted strain WEI-33, exhibited BSH activity. Furthermore, none of the 11 selected strains showed BAP ability.

Up to now, it is not yet completely clear if BSH activity is a desirable trait for promising probiotic strains selection. For one thing, this activity could maximize intestinal survival and persistence of probiotic strains, increasing the overall beneficial effects of the strains (Begley et al. 2006). For another thing, the deconjugation bile salts by BSH enzymes may lead to gastrointestinal malabsorption, and the bile salts deconjugated to free bile acid in the early period may lead a promotion of the occurrence and development of colon cancer, but there is not enough clinical evidence and epidemiological evidence showing that free bile acids are harmful (Vankerckhoven et al. 2008). Our results indicated that all selected strains, except the E. faecium WEI-33, were not able to deconjugate bile salts. Moreover, the strains that did not exhibit BSH activity, such as WEI-9, WEI-10 and WEI-51, were able to survive at different bile salts concentrations, confirming that the two activities are not correlated each other, in accordance with previous report data (Moser and Savage 2001).

Biogenic amines have many types, of which histamine and tyramine are the most toxic. Lactic acid bacteria, which produce biogenic amines, belong to Lactococcus, Lactobacillus, Enterococcus and Leuconostoc, etc., and lactic acid bacteria applied to additives may also produce tyramine and histamine (Moreno-Arribas et al. 2003). Although lactic acid bacteria producing biogenic amines are distributed in various species, the ability to produce biogenic amines is strain-specific. Phenotype detection of histidine, tyrosine, ornithine decarboxylase activities determined by the qualitative liquid culture method showed that none of the 11 strains had any ability to produce biogenic amines. The detection of biogenic amines producing bacteria by conventional culture techniques is often tedious and unreliable, exhibiting disadvantages such as lack of speed, appearance of false positive/negative results and low sensibility (Landeta et al. 2007). As molecular methods are fast, reliable and culture-independent, they represent an interesting alternative for the detection of bacteria producing biogenic amines, a multiplex PCR method was applied to simultaneously detect four genes involved in the production of the main biogenic amines. From the results, the tyrdc gene was detected in E. faecium WEI-9 (Fig. 3), which was inconsistent with the phenotypic results and further confirmed the accuracy of the molecular methods. The remaining strains were negative for all four target genes.

Fig. 3
figure 3

Simultaneous detection of the tyrdc, odc, agdi and hdc genes by multiplex PCR. Lanes: M DM 2000 DNA ladder 100 bp to 2 kb linear scale molecular weight marker (ComWin Biotech, China), 1 E. faecium WEI-9

Conclusions

Following a systematic screening strategy in vitro, the strains E. faecium WEI-10 and L. plantarum WEI-51 were finally selected based on their promising probiotic properties and absence of unsafe characteristics. These two strains could be taken for further investigation in vivo to elucidate their potential health benefits and for application as novel probiotic strains in animal feed supplements.

References

  • Ambadoyiannis G, Hatzikamari M, Litopoulou-Tzanetaki E, Tzanetakis N (2004) Probiotic and technological properties of enterococci isolates from infants and cheese. Food Biotechnol 18:307–325. doi:10.1081/lftb-200035024

    Article  CAS  Google Scholar 

  • Anandharaj M, Sivasankari B (2014) Isolation of potential probiotic Lactobacillus oris HMI68 from mother’s milk with cholesterol-reducing property. J Biosci Bioeng 118:153–159. doi:10.1016/j.jbiosc.2014.01.015

    Article  CAS  PubMed  Google Scholar 

  • Anandharaj M, Sivasankari B, Santhanakaruppu R, Manimaran M, Rani RP, Sivakumar S (2015) Determining the probiotic potential of cholesterol-reducing Lactobacillus and Weissella strains isolated from gherkins (fermented cucumber) and south Indian fermented koozh. Res Microbiol 166:428–439

    Article  CAS  PubMed  Google Scholar 

  • Argyri AA, Zoumpopoulou G, Karatzas KAG, Tsakalidou E, Nychas GJE, Panagou EZ, Tassou CC (2013) Selection of potential probiotic lactic acid bacteria from fermented olives by in vitro tests. Food Microbiol 33:282–291

    Article  CAS  PubMed  Google Scholar 

  • Begley M, Hill C, Gahan CGM (2006) Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 72:1729–1738

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bover-Cid S, Holzapfel WH (1999) Improved screening procedure for biogenic amine production by lactic acid bacteria. Int J Food Microbiol 53:33–41

    Article  CAS  PubMed  Google Scholar 

  • CLSI (2012) Perpormance Standards for Antimicrobial Susceptibility Test; Twenty-Second Informational Supplement. CLSI document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA

    Google Scholar 

  • Collado MC, Gueimonde M, Herna’ndez M, Sanz Y, Salminen S (2005) Adhesion of selected bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion. J Food Protect 68:2672–2678

    Article  Google Scholar 

  • Coton M et al (2010) Occurrence of biogenic amine-forming lactic acid bacteria in wine and cider. Food Microbiol 27:1078–1085

    Article  CAS  PubMed  Google Scholar 

  • Crociani J, Grill JP, Huppert M, Ballongue J (1995) Adhesion of different bifidobacteria strains to human enterocyte‐like Caco‐2 cells and comparison with in vivo study. Lett Appl Microbiol 21:146–148

    Article  CAS  PubMed  Google Scholar 

  • EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) (2012a) Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA J 10:2740

    Article  Google Scholar 

  • EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) (2012b) Guidance on the safety assessment of Enterococcus faecium in animal nutrition. EFSA J 10:2682

    Article  Google Scholar 

  • Elkins CA, Mullis LB (2004) Bile-mediated aminoglycoside sensitivity in lactobacillus species likely results from increased membrane permeability attributable to cholic acid. Appl Environ Microbiol 70:7200–7209. doi:10.1128/aem.70.12.7200-7209.2004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fang Z, Hongfei Z, Junyu Z, Dziugan P, Shanshan L, Bolin Z (2015) Evaluation of probiotic properties of Lactobacillus strains isolated from traditional Chinese cheese. Ann Microbiol 65:1419–1426. doi:10.1007/s13213-014-0980-2

    Article  CAS  Google Scholar 

  • FAO/WHO (2002) Guidelines for the evaluation of probiotic in food. http://www.who.int/foodsafety/publications/fs_management/probiotic2/en/ pp 1–11

  • Fernandez MF, Boris S, Barbes C (2003) Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J Appl Microbiol 94:449–455

    Article  CAS  PubMed  Google Scholar 

  • Freitas AR, Tedim AP, Novais C, Ruiz-Garbajosa P, Werner G, Laverde-Gomez JA, Cantón R, Peixe L, Baquero F, Coque TM (2010) Global spread of the hylEfm colonization-virulence gene in megaplasmids of the Enterococcus faecium CC17 polyclonal subcluster. Antimicrob Agents Chemother 54:2660–2665. doi:10.1128/aac.00134-10

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kos B, Suskovic J, Vukovic S, Simpraga M, Frece J, Matosic S (2003) Adhesion and aggregation ability of probiotic strain Lactobacillus acidophilus M92. J Appl Microbiol 94:981–987. doi:10.1046/j.1365-2672.2003.01915.x

    Article  CAS  PubMed  Google Scholar 

  • Kumar A, Kumar D (2015) Characterization of Lactobacillus isolated from dairy samples for probiotic properties. Anaerobe 33:117–123

    Article  CAS  PubMed  Google Scholar 

  • Landeta G, de las Rivas B, Carrascosa AV, Muñoz R (2007) Screening of biogenic amine production by coagulase-negative staphylococci isolated during industrial Spanish dry-cured ham processes. Meat Sci 77:556–561

    Article  CAS  PubMed  Google Scholar 

  • Laparra JM, Sanz Y (2009) Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium. Lett Appl Microbiol 49:695–701

    Article  CAS  PubMed  Google Scholar 

  • Lee J, Yun HS, Cho KW, Oh S, Kim SH, Chun T, Kim B, Whang KY (2011) Evaluation of probiotic characteristics of newly isolated Lactobacillus spp.: immune modulation and longevity. Int J Food Microbiol 148:80–86

    Article  CAS  PubMed  Google Scholar 

  • Liong MT, Shah NP (2005) Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J Dairy Sci 88:55–66

    Article  CAS  PubMed  Google Scholar 

  • Macias-Rodriguez ME, Zagorec M, Ascencio F, Rojas M (2008) Potential probiotic Lactobacillus strains for piglets from an arid coast. Ann Microbiol 58:641–648

    Article  Google Scholar 

  • Manhar AK, Saikia D, Borah A, Das AS, Gupta K, Roy R, Mahanta CL, Mukhopadhyay R, Manda M (2016) Assessment of goat milk-derived potential probiotic L. lactis AMD17 and its application for preparation of dahi using honey. Ann Microbiol 66:1217–1228. doi:10.1007/s13213-016-1210-x

  • Maragkoudakis PA, Zoumpopoulou G, Miaris C, Kalantzopoulos G, Pot B, Tsakalidou E (2006) Probiotic potential of Lactobacillus strains isolated from dairy products. Int Dairy J 16:189–199

    Article  CAS  Google Scholar 

  • Messaoudi S, Madi A, Prevost H, Feuilloley M, Manai M, Dousset X, Connil N (2012) In vitro evaluation of the probiotic potential of Lactobacillus salivarius SMXD51. Anaerobe 18:584–589

    Article  CAS  PubMed  Google Scholar 

  • Monteagudo-Mera A, Caro I, Rodríguez-Aparicio LB, Rúa J, Ferrero MA, García-Armesto MR (2011) Characterization of certain bacterial strains for potential use as starter or probiotic cultures in dairy products. J Food Protect 74:1379–1386. doi:10.4315/0362-028X.JFP-10-392

    Article  CAS  Google Scholar 

  • Moreno-Arribas MV, Polo MC, Jorganes F, Munoz R (2003) Screening of biogenic amine production by lactic acid bacteria isolated from grape must and wine. Int J Food Microbiol 84:117–123

    Article  CAS  PubMed  Google Scholar 

  • Morrow LE, Gogineni V, Malesker MA (2012) Probiotics in the intensive care unit. Nutr Clin Pract 27:235–241

    Article  PubMed  Google Scholar 

  • Moser SA, Savage DC (2001) Bile salt hydrolase activity and resistance to toxicity of conjugated bile salts are unrelated properties in lactobacilli. Appl Environ Microbiol 67:3476–3480

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Palmer KL, Godfrey P, Griggs A, Kos VN, Zucker J, Desjardins C, Cerqueira G, Gevers D, Walker S, Wortman J, Feldgarden M, Haas B, Birren B, Gilmore MS (2012) Comparative genomics of Enterococci: variation in Enterococcus faecalis, clade structure in E. faecium, and defining characteristics of E. gallinarum and E. casseliflavus. mBio 3:e00318-11. doi:10.1128/mBio.00318-11

  • Pithva S, Shekh S, Dave J, Vyas BRM (2014) Probiotic attributes of autochthonous Lactobacillus rhamnosus strains of human origin. Appl Biochem Biotechnol 173:259–277

    Article  CAS  PubMed  Google Scholar 

  • Pitino L, Randazzo CL, Mandalari G, Lo Curto A, Faulks RM, Le Marc Y, Bisignano C, Caggia C, Wickham MSJ (2010) Survival of Lactobacillus rhamnosus strains in the upper gastrointestinal tract. Food Microbiol 27:1121–1127

    Article  PubMed  Google Scholar 

  • Prasad J, Gill H, Smart J, Gopal PK (1998) Selection and characterisation of Lactobacillus and Bifidobacterium strains for use as probiotics. Int Dairy J 8:993–1002

    Article  Google Scholar 

  • Rice LB, Carias L, Rudin S, Vael C, Goossens H, Konstabel C, Klare I, Nallapareddy SR, Huang W, Murray BE (2003) A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 187:508–512. doi:10.1086/367711

    Article  CAS  PubMed  Google Scholar 

  • Saarela M, Mogensen G, Fondén R, Mättö J, Mattila-Sandholm T (2000) Probiotic bacteria: safety, functional and technological properties. J Biotechnol 84:197–215. doi:10.1016/S0168-1656(00)00375-8

    Article  CAS  PubMed  Google Scholar 

  • Sarem F, SaremDamerdji LO, Nicolas JP (1996) Comparison of the adherence of three Lactobacillus strains to Caco-2 and Int-407 human intestinal cell lines. Lett Appl Microbiol 22:439–442

    Article  CAS  PubMed  Google Scholar 

  • Shobharani P, Halami PM (2016) In vitro evaluation of the cholesterol-reducing ability of a potential probiotic Bacillus spp. Ann Microbiol 66:643–651. doi:10.1007/s13213-015-1146-6

    Article  CAS  Google Scholar 

  • Singh TP, Kaur G, Malik RK, Schillinger U, Guigas C, Kapila S (2012) Characterization of intestinal Lactobacillus reuteri strains as potential probiotics. Probiotics Antimicrob Proteins 4:47–58

    Article  CAS  PubMed  Google Scholar 

  • Solieri L, Bianchi A, Mottolese G, Lemmetti F, Giudici P (2014) Tailoring the probiotic potential of non-starter Lactobacillus strains from ripened Parmigiano Reggiano cheese by in vitro screening and principal component analysis. Food Microbiol 38:240–249

    Article  CAS  PubMed  Google Scholar 

  • Strompfova V, Laukova A (2009) Enterococci from piglets—probiotic properties and responsiveness to natural antibacterial substances. Folia Microbiol 54:538–544

    Article  CAS  Google Scholar 

  • Strompfova V, Laukova A (2014) Isolation and characterization of faecal bifidobacteria and lactobacilli isolated from dogs and primates. Anaerobe 29:108–112

    Article  CAS  PubMed  Google Scholar 

  • Top J, Sinnige JC, Majoor EAM, Bonten MJM, Willems RJL, van Schaik W (2011) The recombinase IntA is required for excision of esp-containing ICEEfm1 in Enterococcus faecium. J Bacteriol 193:1003–1006. doi:10.1128/jb.00952-10

    Article  CAS  PubMed  Google Scholar 

  • Toscano M, De Vecchi E, Gabrieli A, Zuccotti GV, Drago L (2015) Probiotic characteristics and in vitro compatibility of a combination of Bifidobacterium breve M-16 V, Bifidobacterium longum subsp. infantis M-63 and Bifidobacterium longum subsp. longum BB536. Ann Microbiol 65:1079–1086. doi:10.1007/s13213-014-0953-5

    Article  CAS  Google Scholar 

  • Tulini FL, Winkelströter LK, De Martinis ECP (2013) Identification and evaluation of the probiotic potential of Lactobacillus paraplantarum FT259, a bacteriocinogenic strain isolated from Brazilian semi-hard artisanal cheese. Anaerobe 22:57–63

    Article  CAS  PubMed  Google Scholar 

  • Tulumoglu S, Yuksekdag ZN, Beyatli Y, Simsek O, Cinar B, Yasar E (2013) Probiotic properties of lactobacilli species isolated from children’s feces. Anaerobe 24:36–42

    Article  CAS  PubMed  Google Scholar 

  • Vankerckhoven V, Huys G, Vancanneyt M, Vael C, Klare I, Romond MB, Entenza JM, Moreillon P, Wind RD, Knol J, Wiertz E, Pot B, Vaughan EE, Kahlmeter G, Goossens H (2008) Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project. Trends Food Sci Technol 19:102–114

    Article  CAS  Google Scholar 

  • Walter J (2008) Ecological role of lactobacilli in the gastrointestinal tract: implications for fundamental and biomedical research. Appl Environ Microbiol 74:4985–4996

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Werner G, Fleige C, Geringer U, van Schaik W, Klare I, Witte W (2011) IS element IS16 as a molecular screening tool to identify hospital-associated strains of Enterococcus faecium. BMC Infect Dis 11:80. doi:10.1186/1471-2334-11-80

    Article  PubMed  PubMed Central  Google Scholar 

  • Wu HJ, Sun LB, Li CB, Li ZZ, Zhang Z, Wen XB, Hu Z, Zhang YL, Li SK (2014) Enhancement of the immune response and protection against Vibrio parahaemolyticus by indigenous probiotic Bacillus strains in mud crab (Scylla paramamosain). Fish Shellfish Immunol 41:156–162

    Article  PubMed  Google Scholar 

  • Zuo F, Yu R, Feng X, Chen S (2016) Characterization and in vitro properties of potential probiotic Bifidobacterium strains isolated from breast-fed infant feces. Ann Microbiol 66:1027–1037 doi:10.1007/s13213-015-1187-x

Download references

Acknowledgments

This study was funded by the Science and Technology Planning Project of Beijing Municipal Science and Technology Commission of China under Grant No. D161100006116001, and by the program for postdoctoral research in Zhongguancun Haidian Science Park of China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lin Qiao.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feng, Y., Qiao, L., Liu, R. et al. Potential probiotic properties of lactic acid bacteria isolated from the intestinal mucosa of healthy piglets. Ann Microbiol 67, 239–253 (2017). https://doi.org/10.1007/s13213-017-1254-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13213-017-1254-6

Keywords